Found 20 matching trials
Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer PHASE1 This study is a Phase 1b open label, single arm, adaptive multi-centre tria...
Show More Location
Cancer Trials Ireland Investigative Site
Learn More & Join Trial
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients PHASE2 This will be a multi-center, prospective, randomized, single-blinded, place...
Show More Location
Sarcoma Oncology Research Center, LLC
Learn More & Join Trial
Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients. PHASE1 Targeted therapy in the treatment of breast cancer targets HER2 receptor (H...
Show More Learn More & Join Trial
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer PHASE2 DEMETHER is a phase II trial exploring the maintenance of trastuzumab and p...
Show More Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer NA The goal of this clinical trial is to evaluate the efficacy and safety of o...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) PHASE3 The current study will compare PK, efficacy, safety, and immunogenicity of ...
Show More Location
Compassionate Cancer Care Medical Group, Inc.
Learn More & Join Trial
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) PHASE1 The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety. PHASE2 The purpose of this study is to provide post-trial access to alpelisib and ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer PHASE2 This open-label, randomized crossover study evaluated the quality of life, ...
Show More Location
Multiple Locations
Learn More & Join Trial
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors PHASE1 This is a study that will enroll patients with cancer who have tumors that ...
Show More Location
University of Texas Health Science Center at San Antonio
Learn More & Join Trial